Social
#Bestof2020
Plaquenil Does Not Protect Lupus Patients from COVID-19
https://t.co/R5S7phlqYb https://t.co/HDlDfE98RQ
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years 3 months ago
NEJM: Actemra Studied in COVID pneumonia and shown to improve outcomes (mech ventilation or death ;12 vs 19.3%) but did not improve survival (10.4 vs 8.6%). 389 hospitalized pts randomized 2:1 to get 2 IV doses Actemra +SOC vs SOC alone https://t.co/BdslXFXOYD
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years 3 months ago
#Bestof2020 My Experience as a COVID19 Vaccine Trial Participant
https://t.co/bMJoTR5mgv https://t.co/7QJqhXhhCX
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years 4 months ago
Race/ethnicity Associated with Poor Outcomes in Rheum Patients with COVID-19 : Dr. Dey ( @DrMiniDey) #acr20
https://t.co/ecenB2i5At https://t.co/q8QJ5CxqBF
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years 4 months ago
COVID Vaccine Q & A - Dr Kevin Winthrop talks on the use and caveats to COVID-19 vaccination in patients with rheumatic disease and taking biologic and DMARD therapies.
https://t.co/EJL6hVLnrp https://t.co/xkCRRHtkV9
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years 4 months ago
#BestACR20Tweets
Cohort study from NYC shows that patients w/COVID and autoimmune disease were not at an increased risk for a ICU admission, intubation, or death (adjOR 0.79, 95%CI 0.37-1.67). AI pts had more comorbidities (26% vs. 13%), immunosuppressive https://t.co/9mnb05Xqfa
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years 4 months ago
#BestACR20Tweets
Racial/ethnic minorities with rheum Dz(RD) & COVID had increased odds of hospitalization & vent support. 1,324 pts w/ RD+COVID, 36% hospitalized, 6% died. Compared to whites- Blacks Latinos & Asians had higher risk of hospital https://t.co/Aa5UHwvXTA https://t.co/cFk8z8p985
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years 4 months ago
#BestACR20Tweets
RT @KDAO2011 : Abstr#0013 TEASER! Colchicine may improve COVID19 outcomes in hospitalized patients. 50 pts 1:1 colchicine vs. PCB + standard of care: Colchicine group 2X more likely to be d/c from hospital, and less likely to die. Larger studies needed! #ACR20
Dr. John Cush @RheumNow ( View Tweet )
3 years 4 months ago
#Bestof2020: Rheumatic Disease Drugs and COVID-19
https://t.co/82uGbNqm9R https://t.co/U0WyTL5kYZ
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years 4 months ago
#BestACR20Tweets
RT @jeffsparks :Important results from @kmdsilvaMD (newly funded by @RheumResearch): rheumatic patients with COVID with higher risk of hospitalization, ICU admission, CHF, AKI, and VTE than matched comparators. @zach_wallace_md
https://t.co/bmuPBf89xD https://t.co/njHYkbenjy
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years 4 months ago
